Abstract: In February 2024, the National Cancer Center (NCC) published Interpretation of cancer incidence and mortality in China, 2022, which was measured based on the latest national cancer registry and follow-up surveillance data. The data is consistent with the Chinese data from GLOBOCAN 2022, which was released at the same time by the International Agency for Research on Cancer (IARC). The article was published in the Journal of the National Cancer Center and reported on the incidence and death of cancer and their trends in China in 2022. 

Key words: cancer, incidence, mortality, disease burden, trend

摘要： 2024年2月，国家癌症中心发布了《2022年中国癌症发病和死亡报告》，这是基于最新全国肿瘤登记及随访监测数据进行的测算，并与国际肿瘤研究机构（IARC）同期发布的GLOBOCAN 2022的中国数据一致。论文发表于Journal of the National Cancer Center，报告了2022年我国癌症的发病、死亡及其趋势变化。

关键词: 恶性肿瘤, 发病率, 死亡率, 疾病负担, 趋势